Katja Anna Hybel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katja Anna Hybel has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Davíð Rúrik Martinsson A. Højgaard
Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus, Denmark
21 shared publications - Gudmundur Skarphedinsson
Faculty of Psychology, University of Iceland, Reykjavik, Iceland
18 shared publications - Karin Melin
Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
16 shared publications - Bernhard Weidle
Regional Center for Child and Youth Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
15 shared publications - Per Hove Thomsen
Department of Clinical Medicine, Health, Aarhus University
15 shared publications Per Hove Thomsen
Aarhus University Hospital, Aarhus, Denmark
14 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (12) , 3711-3745
CBT and pharmacotherapy after nonresponse for anxiety and obsessive-compulsive disorders in youth: a systematic review and meta-analysis
Approximately half of children with anxiety disorder(s) or obsessive-compulsive disorder (OCD) derive insufficient benefit from first-step evidence-based treatments, including cognitive behavioural therapy (CBT) and pharmacotherapy. Few studies have examined second-step treatment options, and clinical guidelines offer limited direction on subsequent care. This systematic review and meta-analysis synthesises current evidence on interventions for children and adolescents with anxiety disorders or OCD, who showed insufficient response to prior evidence-based treatment. We examined how studies operationalised partial response and non-response, which second-step treatments were provided, and the efficacy of second-step treatments. Five databases were systematically searched up to 21 March 2025, and 40 studies with 49 treatment arms ( N = 1,373) were included, most of which were uncontrolled ( k = 35 of 40 studies) and were identified as a high risk of bias. There was substantial heterogeneity among the included studies, reflecting variety in operationalisations of partial and non-response, and among first-step and second-step treatments. Included second-step interventions were CBT, pharmacotherapy, or combined treatments. Sixteen of the 40 included studies examined second-step interventions in a stepped-care context. Within-group meta-analyses showed large, statistically significant pooled effects of second-step treatments for symptom reduction and general functioning from pre-treatment to post-treatment and to follow-up, both for anxiety disorders and OCD. Remission rates ranged from 6% to 82.4%. Pooled remission rates were 49% at post-treatment and 67% at follow-up for anxiety studies, and 39% at post-treatment and 53% at follow-up for OCD studies. Drop-outs during second-step treatments ranged from 0% to 36.4%, with a pooled drop-out rate of 8% for anxiety studies and 9% for OCD studies. Subgroup analyses on second-step treatment type (CBT, pharmacotherapy, combined) revealed no statistically significant difference between subgroups on any outcome. Overall, the lack of well-designed, controlled stepped-care studies precludes reliable conclusions regarding the efficacy of second-step treatments for youth who benefited insufficiently from initial treatment, despite preliminary indications of positive pre–post changes in symptoms and remission from uncontrolled studies.
- 24 September 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (12) , 3711-3745
Open AccessCBT and pharmacotherapy after nonresponse for anxiety and obsessive-compulsive disorders in youth: a systematic review and meta-analysis
Approximately half of children with anxiety disorder(s) or obsessive-compulsive disorder (OCD) derive insufficient benefit from first-step evidence-based treatments, including cognitive behavioural therapy (CBT) and pharmacotherapy. Few studies have examined second-step treatment options, and clinical guidelines offer limited direction on subsequent care. This systematic review and meta-analysis synthesises current evidence on interventions for children and adolescents with anxiety disorders or OCD, who showed insufficient response to prior evidence-based treatment. We examined how studies operationalised partial response and non-response, which second-step treatments were provided, and the efficacy of second-step treatments. Five databases were systematically searched up to 21 March 2025, and 40 studies with 49 treatment arms ( N = 1,373) were included, most of which were uncontrolled ( k = 35 of 40 studies) and were identified as a high risk of bias. There was substantial heterogeneity among the included studies, reflecting variety in operationalisations of partial and non-response, and among first-step and second-step treatments. Included second-step interventions were CBT, pharmacotherapy, or combined treatments. Sixteen of the 40 included studies examined second-step interventions in a stepped-care context. Within-group meta-analyses showed large, statistically significant pooled effects of second-step treatments for symptom reduction and general functioning from pre-treatment to post-treatment and to follow-up, both for anxiety disorders and OCD. Remission rates ranged from 6% to 82.4%. Pooled remission rates were 49% at post-treatment and 67% at follow-up for anxiety studies, and 39% at post-treatment and 53% at follow-up for OCD studies. Drop-outs during second-step treatments ranged from 0% to 36.4%, with a pooled drop-out rate of 8% for anxiety studies and 9% for OCD studies. Subgroup analyses on second-step treatment type (CBT, pharmacotherapy, combined) revealed no statistically significant difference between subgroups on any outcome. Overall, the lack of well-designed, controlled stepped-care studies precludes reliable conclusions regarding the efficacy of second-step treatments for youth who benefited insufficiently from initial treatment, despite preliminary indications of positive pre–post changes in symptoms and remission from uncontrolled studies.
- Open Access
- 1 May 2024
- Published by Elsevier in Behavior Therapy
- Vol. 56 (1) , 95-109
Metacognition in Children and Adolescents With Obsessive-Compulsive Disorder Treated With Cognitive Behavioral Therapy
- 1 May 2024
- Published by Elsevier in Behavior Therapy
- Vol. 56 (1) , 95-109
Open AccessMetacognition in Children and Adolescents With Obsessive-Compulsive Disorder Treated With Cognitive Behavioral Therapy
- Open Access
- 7 April 2024
- Published by Elsevier in Journal of Obsessive-Compulsive and Related Disorders
- Vol. 41
Metacognitive profiles in children and adolescents with obsessive-compulsive disorder
- 7 April 2024
- Published by Elsevier in Journal of Obsessive-Compulsive and Related Disorders
- Vol. 41
Open AccessMetacognitive profiles in children and adolescents with obsessive-compulsive disorder
- Open Access
- 7 December 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (5) , 519-527
Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments
- 7 December 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (5) , 519-527
Open AccessRemission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments
- Open Access
- 20 June 2023
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 34, 101173
Adverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trial
- 20 June 2023
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 34, 101173
Open AccessAdverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trial
- Open Access
- 18 May 2023
- Published by Springer Nature in Research on Child and Adolescent Psychopathology
- Vol. 51 (8) , 1083-1095
Do Autistic Traits Predict Outcome of Cognitive Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder?
The first aim of this study was to explore whether children with obsessive compulsive disorder (OCD) and subclinical autistic traits can be differentiated from children with OCD without these traits based on clinical OCD-related characteristics, distinct OCD symptom patterns, and type of comorbidity. The second aim was to investigate whether autistic traits predict immediate and long-term outcome of exposure-based cognitive behavioral therapy (CBT) in pediatric OCD.The participants in this study were a total of 257 children and adolescents aged 7–17 years, recruited from Denmark, Norway, and Sweden as a part of the Nordic long-term OCD treatment study (NordLOTS). Inclusion criteria were an OCD diagnosis based on DSM-IV criteria and a Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) total severity score of 16 or higher. No children with a diagnosis on the autism spectrum were included. An Autism Spectrum Screening Questionnaire (ASSQ) cut-off score of ≥ 17 was used to define the group of OCD patients with autistic traits and all participants were treated with 14 weekly sessions of manualized CBT.Comorbid attention-deficit/hyperactivity disorder and tic disorders, subclinical internalizing and externalizing symptoms, lower insight into OCD symptoms, more indecisiveness and pervasive slowness, and ordering/arranging OCD symptoms were found to be significantly associated with having OCD with autistic traits. No difference was found between the groups on treatment outcomes.Results suggest that children and adolescents with OCD and autistic traits portray a different clinical profile than those without these traits, but that CBT is equally effective for those with and without autistic traits.
- 18 May 2023
- Published by Springer Nature in Research on Child and Adolescent Psychopathology
- Vol. 51 (8) , 1083-1095
Open AccessDo Autistic Traits Predict Outcome of Cognitive Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder?
The first aim of this study was to explore whether children with obsessive compulsive disorder (OCD) and subclinical autistic traits can be differentiated from children with OCD without these traits based on clinical OCD-related characteristics, distinct OCD symptom patterns, and type of comorbidity. The second aim was to investigate whether autistic traits predict immediate and long-term outcome of exposure-based cognitive behavioral therapy (CBT) in pediatric OCD.The participants in this study were a total of 257 children and adolescents aged 7–17 years, recruited from Denmark, Norway, and Sweden as a part of the Nordic long-term OCD treatment study (NordLOTS). Inclusion criteria were an OCD diagnosis based on DSM-IV criteria and a Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) total severity score of 16 or higher. No children with a diagnosis on the autism spectrum were included. An Autism Spectrum Screening Questionnaire (ASSQ) cut-off score of ≥ 17 was used to define the group of OCD patients with autistic traits and all participants were treated with 14 weekly sessions of manualized CBT.Comorbid attention-deficit/hyperactivity disorder and tic disorders, subclinical internalizing and externalizing symptoms, lower insight into OCD symptoms, more indecisiveness and pervasive slowness, and ordering/arranging OCD symptoms were found to be significantly associated with having OCD with autistic traits. No difference was found between the groups on treatment outcomes.Results suggest that children and adolescents with OCD and autistic traits portray a different clinical profile than those without these traits, but that CBT is equally effective for those with and without autistic traits.
- 24 April 2023
- Published by Elsevier in Psychiatry Research
- Vol. 324, 115223
Long-term functional impairment in pediatric OCD after and during treatment: An analysis of distinct trajectories
- 24 April 2023
- Published by Elsevier in Psychiatry Research
- Vol. 324, 115223
Long-term functional impairment in pediatric OCD after and during treatment: An analysis of distinct trajectories
- Open Access
- 13 October 2022
- Published by Elsevier in Psychiatry Research
- Vol. 317, 114906
Long- term remission status in pediatric obsessive-compulsive disorder: Evaluating the predictive value of symptom severity after treatment
- 13 October 2022
- Published by Elsevier in Psychiatry Research
- Vol. 317, 114906
Open AccessLong- term remission status in pediatric obsessive-compulsive disorder: Evaluating the predictive value of symptom severity after treatment
- Open Access
- 19 March 2022
- Published by Springer Nature in BMC Psychiatry
- Vol. 22 (1) , 1-15
Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial)
Background: Cognitive behavioural therapy (CBT) is the recommended first-line treatment for children and adolescents with obsessive-compulsive disorder (OCD), but evidence concerning treatment-specific benefits and harms compared with other interventions is limited. Furthermore, high risk-of-bias in most trials prevent firm conclusions regarding the efficacy of CBT. We investigate the benefits and harms of family-based CBT (FCBT) versus family-based psychoeducation and relaxation training (FPRT) in youth with OCD in a trial designed to reduce risk-of-bias. Methods: This is an investigator-initiated, independently funded, single-centre, parallel group superiority randomised clinical trial (RCT). Outcome assessors, data managers, statisticians, and conclusion drawers are blinded. From child and adolescent mental health services we include patients aged 8–17 years with a primary OCD diagnosis and an entry score of ≥16 on the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). We exclude patients with comorbid illness contraindicating trial participation; intelligence quotient < 70; or treatment with CBT, PRT, antidepressant or antipsychotic medication within the last 6 months prior to trial entry. Participants are randomised 1:1 to the experimental intervention (FCBT) versus the control intervention (FPRT) each consisting of 14 75-min sessions. All therapists deliver both interventions. Follow-up assessments occur in week 4, 8 and 16 (end-of-treatment). The primary outcome is OCD symptom severity assessed with CY-BOCS at end-of-trial. Secondary outcomes are quality-of-life and adverse events. Based on sample size estimation, a minimum of 128 participants (64 in each intervention group) are included. Discussion: In our trial design we aim to reduce risk-of-bias, enhance generalisability, and broaden the outcome measures by: 1) conducting an investigator-initiated, independently funded RCT; 2) blinding investigators; 3) investigating a representative sample of OCD patients; 3) using an active control intervention (FPRT) to tease apart general and specific therapy effects; 4) using equal dosing of interventions and therapist supervision in both intervention groups; 5) having therapists perform both interventions decided by randomisation; 6) rating fidelity of both interventions; 7) assessing a broad range of benefits and harms with repeated measures. The primary study limitations are the risk of missing data and the inability to blind participants and therapists to the intervention. Trial registration: ClinicalTrials.gov: NCT03595098, registered July 23, 2018.
- 19 March 2022
- Published by Springer Nature in BMC Psychiatry
- Vol. 22 (1) , 1-15
Open AccessFamily-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial)
Background: Cognitive behavioural therapy (CBT) is the recommended first-line treatment for children and adolescents with obsessive-compulsive disorder (OCD), but evidence concerning treatment-specific benefits and harms compared with other interventions is limited. Furthermore, high risk-of-bias in most trials prevent firm conclusions regarding the efficacy of CBT. We investigate the benefits and harms of family-based CBT (FCBT) versus family-based psychoeducation and relaxation training (FPRT) in youth with OCD in a trial designed to reduce risk-of-bias. Methods: This is an investigator-initiated, independently funded, single-centre, parallel group superiority randomised clinical trial (RCT). Outcome assessors, data managers, statisticians, and conclusion drawers are blinded. From child and adolescent mental health services we include patients aged 8–17 years with a primary OCD diagnosis and an entry score of ≥16 on the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). We exclude patients with comorbid illness contraindicating trial participation; intelligence quotient < 70; or treatment with CBT, PRT, antidepressant or antipsychotic medication within the last 6 months prior to trial entry. Participants are randomised 1:1 to the experimental intervention (FCBT) versus the control intervention (FPRT) each consisting of 14 75-min sessions. All therapists deliver both interventions. Follow-up assessments occur in week 4, 8 and 16 (end-of-treatment). The primary outcome is OCD symptom severity assessed with CY-BOCS at end-of-trial. Secondary outcomes are quality-of-life and adverse events. Based on sample size estimation, a minimum of 128 participants (64 in each intervention group) are included. Discussion: In our trial design we aim to reduce risk-of-bias, enhance generalisability, and broaden the outcome measures by: 1) conducting an investigator-initiated, independently funded RCT; 2) blinding investigators; 3) investigating a representative sample of OCD patients; 3) using an active control intervention (FPRT) to tease apart general and specific therapy effects; 4) using equal dosing of interventions and therapist supervision in both intervention groups; 5) having therapists perform both interventions decided by randomisation; 6) rating fidelity of both interventions; 7) assessing a broad range of benefits and harms with repeated measures. The primary study limitations are the risk of missing data and the inability to blind participants and therapists to the intervention. Trial registration: ClinicalTrials.gov: NCT03595098, registered July 23, 2018.